Eating Disorders & Weight Management News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Wholesale Weight Loss: Sesame Unveils Specialized Care for Weight Loss with Pricing Exclusively for Costco Members
NEW YORK CITY, April 02, 2024 (GLOBE NEWSWIRE) -- Sesame, the company building a radically new healthcare system for uninsured Americans and those with high-deductible plans, today unveiled an expansion of its partnership with Costco to offer specialized health care for weight loss with pricing…#newyorkcity #costco #obese #davidgoldhill #clinicians # #gvvirgingroup #generalcatalyst #giantventures #healthline (Source: Reuters: Health)
Source: Reuters: Health - April 2, 2024 Category: Consumer Health News Source Type: news

Up to 10MILLION Brits 'could be junk food addicts': Experts warn dependence on ultra-processed foods is just as dangerous as being hooked on cocaine or alcohol
Easily available and affordable junk and ultra-processed food has been blamed for fuelling Britain's bulging obesity crisis with experts estimated a fifth of the population could be classified as addicts. (Source: the Mail online | Health)
Source: the Mail online | Health - April 2, 2024 Category: Consumer Health News Source Type: news

Scientists link certain gut bacteria to lower heart disease risk
Changes in the gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease. Now, a team of researchers at the Broad Institute of MIT and Harvard along with Massachusetts General Hospital has found that microbes in the gut may affect cardiovascular disease as well. In a study published in Cell, the team has identified specific species of bacteria that consume cholesterol in the gut and may help lower cholesterol and heart disease risk in people. (Source: World Pharma News)
Source: World Pharma News - April 2, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Obesity in Pregnancy: Do Guidelines Recommend Too Much Weight Gain?
(MedPage Today) -- Pregnancy weight gain below the current minimum recommended by the U.S. Institute of Medicine (IOM) for obese patients did not appear to increase their risk for maternal and fetal complications and was linked to reduced risk... (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - April 1, 2024 Category: OBGYN Source Type: news

How to stop toxic stress making you ill: DR LAWSON WULSIN reveals the very surprising everyday steps you can take
Obesity, diabetes, heart disease, depression and autoimmune disorders such as arthritis are all conditions that can be driven by a hidden cause that doctors very seldom mention: chronic stress. (Source: the Mail online | Health)
Source: the Mail online | Health - April 1, 2024 Category: Consumer Health News Source Type: news

‘Libs of TikTok’ founder slams Southwest Airlines for letting ‘massive obese guy’ take up half her seat
The founder of the popular conservative social media account “Libs of TikTok” lashed out at Southwest Airlines for allegedly allowing a “massive obese guy” encroach on her seat during a flight. Chaya Raichik took to her personal X account, which boasts more than half-a-million followers, to vent…#libsoftiktok #southwestairlines #obese #chayaraichik #raichik #southwestairline #burgerkingsodacup #southwest (Source: Reuters: Health)
Source: Reuters: Health - April 1, 2024 Category: Consumer Health News Source Type: news

Now KIDS are going to get Ozempic! NHS-affiliated trial will give dozens of fat children as young as SIX the powerful slimming jabs
Weight loss injection semaglutide, branded as Ozempic and Wegovy, has already been rolled out for adults but a new trial seeks to firm up evidence to use them for obese children. (Source: the Mail online | Health)
Source: the Mail online | Health - April 1, 2024 Category: Consumer Health News Source Type: news

The race to develop the next generation of weight-loss drugs
Novo Nordisk and Eli Lilly, plus a clutch of rivals, aim to cut side effects while treating obesity-linked diseases (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 1, 2024 Category: Pharmaceuticals Source Type: news

Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
Ozempic could be profitably produced for less than $5 a month even as maker Novo Nordisk A/S charges almost $1,000 in the US, according to a study that revives questions about prices for top-selling treatments for diabetes and obesity. The blockbuster drug could be manufactured for 89 cents to…#novonordiskas #yaleuniversity #kingscollegehospital #novo #ozempicandwegovy #catalentinc #medicare #berniesanders #vermont #novonordisk (Source: Reuters: Health)
Source: Reuters: Health - March 30, 2024 Category: Consumer Health News Source Type: news

How WW, Noom Say They're Filling Obesity Medicine Gaps
While applauding the role that these behavior-based weight management programs play in a comprehensive approach, an academic weight loss doctor thinks the order is backward. (Source: WebMD Health)
Source: WebMD Health - March 29, 2024 Category: Consumer Health News Source Type: news

More Physical Activity Needed to Cut Risk for Obesity Among Those With Genetic Risk
FRIDAY, March 29, 2024 -- The daily step count needed to reduce the risk for obesity varies based on an individual ' s genetic risk for higher body mass index (BMI), according to a study published online March 27 in JAMA Network Open.Evan L.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 29, 2024 Category: Pharmaceuticals Source Type: news

Obesity in Childhood Doubles Odds for MS in Young Adulthood
FRIDAY, March 29, 2024 -- Children who are obese face double the odds of developing multiple sclerosis later in life, a new study warns.The overall odds for any one child to develop the neurodegenerative illness remains very low. However, the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 29, 2024 Category: General Medicine Source Type: news

Weight loss biotech plans IPO as demand builds for anti-obesity treatments
Aardvark Therapeutics’ drug has been shown in trials to suppress cravings in patients with rare genetic form of obesity (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 29, 2024 Category: Pharmaceuticals Source Type: news

Obese children twice as likely to develop multiple sclerosis, study suggests
Swedish researchers say inflammation caused by obesity is likely to increase risk of developing conditions such as MSChildren who are obese may face more than double the risk of developing multiple sclerosis as adults, a study suggests.MS can affect the brain and spinal cord, causing a range of potential symptoms including problems with vision, arm or leg movement, sensation or balance. It is a lifelong condition that can sometimes cause serious disability.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 28, 2024 Category: Science Authors: Andrew Gregory Health editor Tags: Obesity Multiple sclerosis Children's health Society Medical research Science Source Type: news

Eli Lilly in advanced clinical trials for its weight-loss pill
Eli Lilly has commenced phase three clinical trials in India for a new oral weight-loss drug called orforglipron. The trials aim to assess its safety and efficacy compared to insulin glargine in individuals with type-two diabetes and obesity or overweight at an increased cardiovascular risk. The company's spokesperson in India mentioned ongoing clinical studies on novel products, including orforglipron. (Source: The Economic Times)
Source: The Economic Times - March 28, 2024 Category: Consumer Health News Source Type: news